Search

everythinglearnresearchcommunity

for

Search:↓

Deleting vitamin D and calcium receptors in skin cells increases skin cancer risk by reducing DNA repair and stress response.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Patched1 helps prevent tumors by controlling cell growth.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

Enhancing immune response can improve cancer treatment effectiveness.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Enhancing Tregs can protect against alopecia areata.

Blocking certain immune signals can reduce skin damage from radiation therapy.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

Cetuximab can cause eyelash growth, which is rare but manageable.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Some blood pressure medications are linked to a higher risk of skin cancer.

Certain genetic variants impair enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Two new compounds were found that could promote hair growth as well or better than minoxidil.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.